Clinical Trial Update: n3 PUFA and Muscle-disuse Atrophy in Young Women [NA]

View source ↗

Summary

A completed clinical trial evaluating omega-3 polyunsaturated fatty acids (n3 PUFA) for muscle disuse atrophy in young women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Atrophy

Drugs mentioned

• Omega-3 polyunsaturated fatty acids (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: McMaster University | Conditions: Muscle Atrophy | NA | Status: COMPLETED